Polycystic ovary syndrome: Insight into pathogenesis and a common association with insulin resistance

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 16, Issue 3, 2016, Pages 262-266

  Barber, Thomas M ^a   Dimitriadis, George K ^a   Andreou, Avgi ^a   Franks, Stephen ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Insulin resistance; Metabolic dysfunction; Obesity; PCOS

Indexed keywords

ARTICLE; BROWN ADIPOSE TISSUE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DYSLIPIDEMIA; FATTY LIVER; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHENOTYPE; WEIGHT GAIN; COMPLICATION; FEMALE; PATHOPHYSIOLOGY;

FEMALE; HUMANS; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME;

EID: 85013969288     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.16-3-262     Document Type: Article

References (30)

1. Asuncion M, Calvo RM, San Millan JL et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-8.
2. Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 2006;65:137-45.
3. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). H um Reprod 2004;19:41-7.
4. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries - a common finding in normal women. Lancet 1988;1:870-2.
5. Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995;80:2586-93.
6. Barber TM, Bennett AJ, Groves CJ et al. A ssociation of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia 2008;51:1153-8.
7. Ramezani-Binabaj M, Motalebi M et al. A re women with polycystic ovarian syndrome at a high risk of non-alcoholic fatty liver disease; a meta-analysis. Hepat Mon 2014;14:e23235.
8. Barber TM, McCarthy MI, Franks S, Wass JA. Metabolic syndrome in polycystic ovary syndrome. Endokrynol Pol 2007;58:34-41.
9. Ehrmann DA. Metabolic dysfunction in PCOS: relationship to obstructive sleep apnea. Steroids 2012;77:290-4.
10. Venkatesan AM, Dunaif A, Corbould A. Insulin resistance in polycystic ovary syndrome: progress and paradoxes. Recent Prog Horm Res 2001;56:295-308.
11. Franks S, Mason H, White D, Willis D. Mechanisms of anovulation in polycystic ovary syndrome. Steroids 1997;62:728.
12. Morin-Papunen LC, Vauhkonen I et al. I nsulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. Hum Reprod 2000;15:1266-74.
13. Willis DS, Watson H, Mason HD et al. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 1998;83:3984-91.
14. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
15. Yki-Jarvinen H, Makimattila S, Utriainen T, Rutanen EM. Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 1995;80:3227-32.
16. Cusi K, Maezono K, Osman A et al. I nsulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000;105:311-20.
17. Rice S, Christoforidis N, Gadd C et al. I mpaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Hum Reprod 2005;20:373-81.
18. Vassiliadi DA, Barber TM, Hughes BA et al. I ncreased 5 alphareductase activity and adrenocortical drive in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009;94:3558-66.
19. Barber TM, Wass JA, McCarthy MI, Franks S. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007;66:513-7.
20. Vaggopoulos V, Trakakis E, Chrelias C et al. C omparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance. J Endocrinol Invest 2013;36:478-84
21. Zhang H Y, Zhu F F, Xiong J et al. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG 2009;116:1633-9.
22. Zhuang XF, Zhao MM, Weng CL, Sun NL. Adipocytokines: a bridge connecting obesity and insulin resistance. Med Hypotheses 2009;73:981-5.
23. Barber TM, Franks S. Adipocyte biology in polycystic ovary syndrome. Mol Cell Endocrinol 2013;373:68-76.
24. Barber TM, Golding SJ, Alvey C et al. Global adiposity rather than abnormal regional fat distribution characterises women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:999-1004.
25. Manneras-Holm L, Leonhardt H, Kullberg J et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab 2011;96:E304-11.
26. Carmina E, Bucchieri S, Esposito A et al. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007;92:2500-5.
27. Escobar-Morreale HF. Surgical management of metabolic dysfunction in PCOS. Steroids 2012;77:312-6.
28. Cypess AM, Lehman S, Williams G et al. I dentification and importance of brown adipose tissue in adult humans. N Engl J Med 2009;360:1509-17.
29. Virtanen KA, Lidell ME, Orava J et al. Functional brown adipose tissue in healthy adults. N Engl J Med 2009;360:1518-25.
30. Reddy NL, Jones TA, Wayte SC et al. Identification of brown adipose tissue using MR imaging in a human adult with histological and immunohistochemical confirmation. J Clin Endocrinol Metab 2014;99:E117-21.